Aclaimant, a Chicago-based risk management software company, today announced the U.S. Patent and Trademark Office (USPTO) has awarded it patent number 12,198,195 for its groundbreaking approach to ...
SINGAPORE, Feb. 11, 2025 /PRNewswire/ -- A NEW breast cancer therapy shown to significantly reduce the risk of cancer recurrence and improve disease-free survival in women is now approved for use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback